Sinopharm Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	8,431	8,557	8,169	7,940	6,787	7,591
Market Cap Growth	3.88%	4.75%	2.88%	16.99%	-10.59%	-29.97%
Enterprise Value	21,631	23,029	20,352	19,036	19,278	16,823
Last Close Price	2.35	2.38	2.27	2.31	2.06	2.26
PE Ratio	8.48	8.86	6.40	6.42	5.56	6.90
PS Ratio	0.10	0.11	0.10	0.10	0.08	0.11
PB Ratio	0.45	0.49	0.48	0.50	0.43	0.55
P/TBV Ratio	0.83	0.89	0.90	0.95	0.84	1.08
P/FCF Ratio	3.17	6.20	3.81	2.91	5.96	5.35
P/OCF Ratio	2.97	5.41	3.37	2.61	4.63	4.44
EV/Sales Ratio	0.27	0.29	0.24	0.24	0.24	0.24
EV/EBITDA Ratio	6.67	8.42	5.91	5.30	5.35	5.26
EV/EBIT Ratio	8.31	9.43	6.47	5.77	5.84	5.75
EV/FCF Ratio	8.12	16.68	9.49	6.97	16.93	11.86
Debt / Equity Ratio	0.63	0.60	0.61	0.63	0.69	0.76
Debt / EBITDA Ratio	3.79	3.42	2.78	2.60	2.76	3.04
Debt / FCF Ratio	4.39	7.58	4.85	3.69	9.45	7.40
Asset Turnover	-	1.51	1.60	1.58	1.61	1.57
Inventory Turnover	-	8.83	9.06	8.98	9.68	9.28
Quick Ratio	1.07	1.06	1.06	0.99	1.01	0.99
Current Ratio	1.35	1.39	1.40	1.36	1.33	1.31
Return on Equity (ROE)	-	8.44%	13.03%	13.68%	13.78%	14.50%
Return on Assets (ROA)	-	2.87%	3.73%	4.06%	4.06%	4.11%
Return on Invested Capital (ROIC)	7.13%	9.74%	13.84%	14.48%	14.19%	15.09%
Return on Capital Employed (ROCE)	12.20%	12.50%	15.70%	17.50%	18.10%	17.80%
Earnings Yield	11.79%	11.29%	15.63%	15.57%	17.99%	14.50%
FCF Yield	31.59%	16.13%	26.26%	34.39%	16.78%	18.68%
Dividend Yield	4.01%	3.91%	5.39%	5.14%	5.72%	4.68%
Payout Ratio	10.73%	38.51%	28.26%	27.45%	27.75%	25.95%
Buyback Yield / Dilution	0.36%	-	-0.12%	0.12%	-0.30%	-4.70%
Total Shareholder Return	4.36%	3.91%	5.27%	5.27%	5.42%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.